CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,976,580
- in 4 filings, $5.0M under 10b5-1 plans
Net −$4,976,580. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-21 | Hunt Anthony Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −7,916 | 1 | ||
| 2020-05-21 | Hunt Anthony Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −39,037 | 0 | ||
| 2020-05-21 | Hunt Anthony Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −3,086 | 50,154 | ||
| 2020-05-20 | DAWES KAREN A Director | Sale | −10 | $135.91 | $1K | 119,946 |
| 2020-05-20 | DAWES KAREN A Director | Sale | −43 | $136.98 | $6K | 119,903 |
| 2020-05-20 | DAWES KAREN A Director | Sale | −282 | $139.40 | $39K | 119,621 |
| 2020-05-20 | DAWES KAREN A Director | Sale | −182 | $140.29 | $26K | 119,439 |
| 2020-05-18 | BARTHELEMY NICOLAS Director | Exercise or conversion | +2,109 | $67.71 | $143K | 5,673 |
| 2020-05-18 | BARTHELEMY NICOLAS Director | Sale | −3,009 | $142.53 | $429K | 2,664 |
| 2020-05-18 | BARTHELEMY NICOLAS Director | Exercise or conversion · Stock Option (Right to Buy) | +2,109 | 0 | ||
| 2020-05-18 | DAWES KAREN A Director | Sale | −712 | $135.76 | $97K | 120,844 |
| 2020-05-18 | DAWES KAREN A Director | Sale | −160 | $136.92 | $22K | 120,684 |
| 2020-05-18 | DAWES KAREN A Director | Sale | −269 | $138.60 | $37K | 120,415 |
| 2020-05-18 | DAWES KAREN A Director | Sale | −122 | $139.32 | $17K | 120,293 |
| 2020-05-18 | DAWES KAREN A Director | Sale | −180 | $140.62 | $25K | 120,113 |
| 2020-05-18 | DAWES KAREN A Director | Sale | −77 | $141.45 | $11K | 120,036 |
| 2020-05-18 | DAWES KAREN A Director | Sale | −80 | $142.45 | $11K | 119,956 |
| 2020-05-18 | DAWES KAREN A Director | Sale | −712 | $135.76 | $97K | 120,844 |
| 2020-05-18 | DAWES KAREN A Director | Sale | −160 | $136.92 | $22K | 120,684 |
| 2020-05-18 | DAWES KAREN A Director | Sale | −269 | $138.60 | $37K | 120,415 |
Page 34 of 42 · 832 trades